About

Robert Vance is the Vice President of New Markets for Gentex Corporation, a leading provider of advanced electronic products and features for the automotive, aerospace, fire protection, and medical industries. He is responsible for the strategic development of new markets, technologies, and partnerships that can grow to provide a secure and substantial future for Gentex’s products and team. In prior roles, Robert built an extensive background serving in various positions in Finance, Operations, Business Development and Management, and Executive Leadership. Robert holds a Bachelor of Arts in Business Administration from Hope College with a focus on Finance and Foreign Languages, and completed his graduate studies at Meiji Gakuin University in Japan. In addition to his role on the board at PhotoniCare, he serves on the board at various other technology, medical, and manufacturing companies including Solace Power, ADASKY, and Wolverine Assemblies.

Cary Vance was appointed Chairman, President and CEO of PhotoniCare in May 2023, bringing over 20 years of global MedTech executive experience. Previously, he served as President & CEO of Titan Medical, Xcath Incorporated, OptiScan Biomedical, Myoscience Incorporated and Hansen Medical; strategically transforming and commercializing these businesses and markets with disruptive, enabling and game-changing novel technologies. Cary has executed on equity and debt financing strategies as an integral step to successful value creation and M&A events. Prior to his CEO role at Hansen Medical, he served in various global executive leadership roles at Teleflex, Covidien and GE HealthCare. Cary is Lean/Six Sigma Black Belt Certified, and earned both a Bachelor of Arts degree in Economics and an MBA from Marquette University.

Mr. Grogan is a Managing Director of MCN/Grand Angels.  He has been a member of the Investment Review Board of the Michigan Pre-Seed Fund since 2009. He is a former managing director for Michigan Accelerator Fund I, MAF Opportunity Fund LP and Acuity Partners Ltd., former chairman of nanoRETE Inc., former advisory board director for Michigan Israel Business Bridge, former director of MichBio, former director of MIT Enterprise Forum Michigan, former adviser for Novus Biotechnology Fund I LP, and former chief strategist for LifeMed ID Inc. and SMART Association Inc. (where he also was director of smart card initiatives). He also is the former CEO of Leapfrog Smart Products and Conduit Healthcare Solutions Inc.

Dr. Haroon brings over two decades of experience in drug development, corporate/business development and investment as he leads Julz Co., a US-based investment fund focused on healthcare. He has been involved in transactions and fund-raising efforts that total in billions of dollars. He started his career at Duke University Medical Center as faculty, focused on research in oncology and angiogenesis. He started his first company while he was at Duke, and was later recruited to lead Drug Discovery at SRI International (formerly Stanford Research Institute) in Menlo Park, CA. His focus at SRI included not only internal drug development efforts and NIH funded research, but also setting up a pre-clinical CRO helping both small biotech and Major pharmaceuticals. Subsequently, he headed corporate and business development at Synergenics, a venture group in San Francisco led by Bill Rutter, former Chairman and CEO of Chiron. In addition to his regular duties, he also established one of the first Biotech Innovation centers in the San Francisco Bay area. He moved on to head up the life sciences business (a P&L of over $1 Billion with offices in over 22 countries) at VWR International, a CDR (Clayton, Dubilier & Rice, private equity) owned company. After he left VWR, he consulted extensively with biotech and multinational CROs on matters of corporate and business development. He joined UNC Chapel Hill and had numerous roles as Director, Professor, Senior Advisor and Associate Dean over the years in Schools of Medicine, Business and Pharmacy. He led efforts in recasting the commercialization efforts, fund raising (largest single fund raise i.e., $100M) and major center grants (Nanotechnology). He continued his consulting efforts under his company Medbioz, and helped C-level management in biotech, pharmaceuticals and the investment arena. He still maintains a partial appointment at UNC Chapel Hill as Professor and Director of the Department of Ophthalmology, in the School of Medicine. He is currently Chairman of the Board for Julz and Blue Jay Mobile Health, and Board Director of Calcivis and Stent Tek. Dr Haroon received his PhD from Duke University Medical Center and his Bachelor’s and Medical Degrees from Punjab University, Pakistan. He carried out his post-doctoral training at Duke University Medical Center and a brief stint as Lab Medicine Fellow at UNC Chapel Hill.

Mr. Zeller is Senior Vice President and Chief Privacy Officer at Aristocrat Leisure Limited.  He has over 15 of experience in the pharmaceutical and medical technology industries with Gilead Sciences, Abbott Labs, Amgen, and Horizon Therapeutics. He advises on complex global legal, compliance, and regulatory issues.   Patrick is a frequent author and speaker on privacy, data protection, and cyber security issues. He was an Adjunct Professor at the University of Illinois, Chicago College of Law.  He is also a member of the Board of Governors for Gilda Club Chicago and a former board member for the International Pharmaceutical Privacy Consortium and the Medical Device Consortium.  

Dr. Shelton is a passionate and motivated business-focused engineer with a profound personal connection to the problem PhotoniCare is solving. He received a B.S. in Electrical Engineering from Oklahoma State University and a Ph.D. in Bioengineering from Texas A&M University, followed by three years of post-doctoral research at the University of Illinois. He has been building optical imaging systems for 20 years and managing engineering teams for 15 years. He leads PhotoniCare as its CEO and drives the company’s long-term vision and strategic plan. He has experience raising private financings, as well as negotiating and executing various research contracts, license agreements, distribution agreements, and other business development activities. He is passionate about his family, mountain biking, and music.

Dr. Shelton is a passionate and motivated business-focused engineer with a profound personal connection to the problem PhotoniCare is solving. He received a B.S. in Electrical Engineering from Oklahoma State University and a Ph.D. in Bioengineering from Texas A&M University, followed by three years of post-doctoral research at the University of Illinois. He has been building optical imaging systems for 20 years and managing engineering teams for 15 years. He leads PhotoniCare as its CEO and drives the company’s long-term vision and strategic plan. He has experience raising private financings, as well as negotiating and executing various research contracts, license agreements, distribution agreements, and other business development activities. He is passionate about his family, mountain biking, and music.

Steve is a professor, physician-engineer, and serial entrepreneur. He has dedicated his career to creating innovative optical imaging systems for biological discovery and medical applications.

Chien Huang was appointed VP Finance of PhotoniCare in Dec 2024, bringing over 25 years of experience in pharmaceutical and MedTech space implementing financial systems to support the achievement of corporate value creation. Most recently, he served as CFO of Titan Medical Inc. A medical device company headquartered in Toronto, Ontario and with operations in Chapel Hill, North Carolina, focused on enhancing robotic assisted surgery using innovative technology through a single access point.  Prior to Titan, Chien served in executive leadership roles at various public-listed companies including Quarterhill, Aralez Pharmaceuticals, Astellas Pharma and Draxis Health.  Chien holds a Bachelor of Science in Physiology from the University of Toronto and a Graduate Accounting from McGill University.  Chien is a member of CPA Canada.

Christopher Walker joined PhotoniCare as the Vice President of Sales in November 2024. During the past 20 years he has worked at Teleflex and Covidien in various leadership roles ranging from sales, market development, channel marketing, sales training, and most recently was the VP of Sales for Latin America. Christopher earned a Bachelors of Science degree at the University of Pittsburgh.

Alex is an Entrepreneurial Medical Device Product Manager with background in Electronic Engineering, Software Development and self-taught web development. He is an expert in identifying customer problems and developing creative solutions.

Kelly Petrucci is a distinguished market access leader with over two decades of experience in the healthcare industry, specializing in pharmaceuticals, durable medical equipment, biologics, and medical devices. As the Executive Vice President of Operations and Strategy at PRIA, Kelly spearheads the operations team, which includes account management, case management, and patient access leadership. Her role involves managing operational processes, ensuring strategic oversight, and optimizing customer satisfaction. Kelly's expertise encompasses strategic support, patient access programs, and healthcare policy. In her previous role as CEO of Ascend Access Healthcare, she led a market access consulting organization that delivered comprehensive market access strategies to companies, including prior authorization, market landscape assessments, commercial strategy, healthcare policy, and payer dynamics. Prior to Ascend Access Healthcare, Kelly served as the Global Vice President of Strategy and Market Access for Gynesonics. There, she achieved coverage for 280 million lives, including 99% of all Blue Cross Blue Shield plans in the US. Under her leadership, the organization transitioned from a temporary Category III Code to a successful Category I code, showcasing her ability to drive impactful outcomes. Kelly's leadership experience includes managing multi-functional teams both on-site and remotely. Her responsibilities have spanned in-house authorizations, benefit verifications, data analytics, payer relations, and program design. She collaborates closely with the CEO and other senior leaders to execute daily tasks, contribute to company strategy, and drive improvements in processes, efficiencies, and technology enhancements. MANAGED MARKETS & HEALTH CARE POLICY / ECONOMIC DIRECTOR Health Policy • Risk Share/ Value Based Contracting • Coding Application• Reimbursement Negotiations •Account Management • Pharmacy & DME Formulary Access • Product Launch • Contract / Rebate Negotiations • RAM Team Management